Oculis Holding AG (OCS)
NASDAQ: OCSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
OCS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $523.50M
- EPS (TTM)
- -$1.74
- Dividend yield
- None
- 52-week range
- 8.30 – 34.48
- Day range
- 8.36 – 8.83
- Volume / Avg
- 173.68K / 259.47K
- Beta
- —
- Shares outstanding
- 61.59M
52-week range
OCS stock today
On Oct 7, OCS ended the session at $8.50, shedding $0.22 (2.52%), versus the S&P 500's 0.22% decline. Shares are 75.3% below their 52-week high of $34.48, set on May 11, 2026 and 2.4% above the 52-week low of $8.30, near the bottom of the past year's range. OCS is down 57.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 55.4%.
Oculis has posted a net loss over the last twelve months (EPS of -$1.74), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Oculis
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Oculis peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MPLTMapLight Therapeutics Inc. | 9.36 | -3.41% | $520.19M | vs OCS |
| BLSMBlossomHill Therapeutics Inc. | 16.61 | -3.93% | $527.95M | vs OCS |
| NGNENeurogene Inc. | 25.87 | +1.65% | $517.69M | vs OCS |
| ALTAltimmune Inc. | 2.66 | -0.37% | $517.42M | vs OCS |
| DRUGBright Minds Biosciences Inc. | 52.00 | +7.77% | $512.93M | vs OCS |
| EOLSEvolus Inc. | 7.74 | +4.88% | $511.23M | vs OCS |
| PBYIPuma Biotechnology Inc | 9.81 | +3.26% | $506.39M | vs OCS |
| CBIOCrescent Biopharma Inc. | 13.49 | -0.59% | $501.11M | vs OCS |
Indexes, lists and sector
Oculis stock FAQ
What is Oculis's stock price today?
OCS last traded at $8.50 as of Oct 7, 4:00 PM EDT, down 2.52% on the day. Prices are delayed at least 15 minutes.
What is the OCS 52-week high?
The 52-week high for OCS is $34.48 and the 52-week low is $8.30. The stock is currently 75.3% below its high.